Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$64,818,985
+$2,722,426 QoQ
Shares Held
255,223
+0.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#394
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewEdge Wealth, LLC holds $502,588,092 across 13 Drug Manufacturers - General names. JNJ ranks #5 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
422,116 | $106,221,270 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
754,019 | $95,262,760 | |
| 3 | NVS |
Novartis AG
|
579,486 | $90,817,045 | |
| 4 | LLY |
ELI LILLY & Co
|
64,986 | $77,946,164 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
255,223 | $64,818,985 | |
| 6 | AMGN |
Amgen Inc
|
110,074 | $39,859,996 | |
| 7 | MRK |
Merck & Co., Inc.
|
64,900 | $8,339,650 | |
| 8 | AZN |
Astrazeneca PLC
|
33,124 | $6,280,972 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,818,985 | 255,223 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $62,096,559 | 254,036 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $53,748,640 | 259,718 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $43,749,292 | 235,947 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $34,925,982 | 228,648 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $36,208,178 | 218,332 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $29,366,103 | 203,057 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $30,395,001 | 187,554 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,691,472 | 114,200 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $18,493,518 | 116,907 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $16,623,060 | 106,055 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $14,390,988 | 92,398 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $13,733,359 | 82,971 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $17,518,720 | 113,024 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $18,587,996 | 105,225 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,183,585 | 99,067 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,940,930 | 89,803 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $12,640,929 | 71,325 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $11,157,356 | 65,221 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $9,962,289 | 61,686 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,723,284 | 59,022 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,524,177 | 51,866 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,411,691 | 15,324 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||